J. McKendrick

1.7k total citations
26 papers, 1.2k citations indexed

About

J. McKendrick is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, J. McKendrick has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in J. McKendrick's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). J. McKendrick is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and Colorectal Cancer Surgical Treatments (6 papers). J. McKendrick collaborates with scholars based in Australia, United Kingdom and Italy. J. McKendrick's co-authors include David D. MacNicol, D.R. Wilson, Chris Twelves, Jim Cassidy, Jean A. Maroun, A. Garin, Guy van Hazel, Michael Boyer, Eduardo Díaz‐Rubio and Ullrich Graeven and has published in prestigious journals such as Nature, Chemical Society Reviews and Journal of Clinical Oncology.

In The Last Decade

J. McKendrick

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. McKendrick Australia 13 871 308 257 237 122 26 1.2k
Robert M. OʼBryan United States 18 960 1.1× 216 0.7× 301 1.2× 636 2.7× 83 0.7× 44 1.5k
Salitha Reddy United States 18 571 0.7× 218 0.7× 200 0.8× 552 2.3× 87 0.7× 29 1.3k
Hugh L. Davis United States 19 517 0.6× 180 0.6× 221 0.9× 276 1.2× 46 0.4× 46 1.1k
John J. Gullo United States 10 1.0k 1.2× 201 0.7× 204 0.8× 361 1.5× 65 0.5× 18 1.3k
Virginie Lucas United States 13 779 0.9× 429 1.4× 103 0.4× 235 1.0× 99 0.8× 24 1.1k
Jean Marc Extra France 11 857 1.0× 115 0.4× 252 1.0× 210 0.9× 39 0.3× 21 1.7k
M. De Lena Italy 21 1.1k 1.3× 427 1.4× 448 1.7× 474 2.0× 61 0.5× 94 2.3k
Giuseppe Fraschini United States 23 1.4k 1.6× 428 1.4× 221 0.9× 319 1.3× 28 0.2× 53 2.1k
G. Pérez-Manga Spain 13 1.1k 1.3× 244 0.8× 282 1.1× 322 1.4× 19 0.2× 25 1.3k
Gladys Rodriguez United States 23 1.5k 1.7× 139 0.5× 166 0.6× 500 2.1× 85 0.7× 57 2.1k

Countries citing papers authored by J. McKendrick

Since Specialization
Citations

This map shows the geographic impact of J. McKendrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. McKendrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. McKendrick more than expected).

Fields of papers citing papers by J. McKendrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. McKendrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. McKendrick. The network helps show where J. McKendrick may publish in the future.

Co-authorship network of co-authors of J. McKendrick

This figure shows the co-authorship network connecting the top 25 collaborators of J. McKendrick. A scholar is included among the top collaborators of J. McKendrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. McKendrick. J. McKendrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ngan, Samuel Y., Mathias Bressel, Bev McClure, et al.. (2014). A Phase II Trial of Integrated Preoperative Radiotherapy and Chemotherapy with Oxaliplatin 5-Fluorouracil and Folinic Acid in Patients with Locally Advanced Rectal Cancer: Trans-Tasman Radiation Oncology Group TROG 09.01. International Journal of Radiation Oncology*Biology*Physics. 90(1). S21–S22. 1 indexed citations
2.
3.
Twelves, C.J., Werner Scheithauer, J. McKendrick, et al.. (2007). 1LB 5-year overall survival update from the X-ACT trial of capecitabine vs. 5-FU/LV as adjuvant treatment for stage-III colon cancer. European Journal of Cancer Supplements. 5(6). 1–1. 11 indexed citations
4.
Geldart, T., et al.. (2006). Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure. British Journal of Urology. 98(2). 353–358. 29 indexed citations
5.
Twelves, C.J., Alex Wong, J. McKendrick, et al.. (2005). Updated efficacy findings from the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes’ C colon cancer. Journal of Clinical Oncology. 23(16_suppl). 3521–3521. 10 indexed citations
6.
Ngan, Samuel Y., Michael Michael, John Mackay, et al.. (2004). A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. British Journal of Cancer. 91(6). 1019–1024. 61 indexed citations
7.
Cassidy, Jim, Werner Scheithauer, J. McKendrick, et al.. (2004). Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3509–3509. 58 indexed citations
8.
Cassidy, Jim, Werner Scheithauer, J. McKendrick, et al.. (2004). Capecitabine (X) vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT study): positive efficacy results of a phase III trial. Journal of Clinical Oncology. 22(14_suppl). 3509–3509. 20 indexed citations
9.
Kröning, H., Andrés Cervantes, J. McKendrick, et al.. (2003). 1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study). European Journal of Cancer Supplements. 1(5). S326–S326. 3 indexed citations
10.
Aristides, M, et al.. (2002). Economic Evaluation of Gemcitabine Alone and in Combination with Cisplatin in the Treatment of Nonsmall Cell Lung Cancer. PharmacoEconomics. 20(5). 325–337. 34 indexed citations
11.
Cassidy, Jim, Chris Twelves, Eric Van Cutsem, et al.. (2002). First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous5-fluorouracil/leucovorin. Annals of Oncology. 13(4). 566–575. 422 indexed citations
12.
Mead, Graham M., Matthew R. Sydes, Jan Walewski, et al.. (2002). An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt’s lymphoma: results of United Kingdom Lymphoma Group LY06 study. Annals of Oncology. 13(8). 1264–1274. 212 indexed citations
13.
Vukelja, S., Vladimir Moiseyenko, Robert Leonard, et al.. (2001). Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results. Breast Cancer Research and Treatment. 69(3). 6 indexed citations
14.
Rischin, Danny, Jennifer Smith, Michael Millward, et al.. (2000). A phase II trial of paclitaxel and epirubicin in advanced breast cancer. British Journal of Cancer. 83(4). 438–442. 6 indexed citations
15.
16.
Sweetenham, John, J. McKendrick, Graham M. Mead, & J. M. A. Whitehouse. (1993). Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma. European Journal of Cancer. 29(2). 190–192. 4 indexed citations
17.
Simmonds, Peter, Morry Silberstein, & J. McKendrick. (1993). Thymic hyperplasia in adults following chemotherapy for malignancy. Australian and New Zealand Journal of Medicine. 23(3). 264–267. 13 indexed citations
18.
MacNicol, David D., J. McKendrick, & D.R. Wilson. (1978). Clathrates and molecular inclusion phenomena. Chemical Society Reviews. 7(1). 65–65. 124 indexed citations
19.
HARDY, A. D. U., David D. MacNicol, J. McKendrick, & D.R. Wilson. (1975). A study of the role of hydrogen bonding in clathrate formation. Tetrahedron Letters. 16(52). 4711–4712. 3 indexed citations
20.
McKendrick, J., et al.. (1973). Novel ring contraction leading to the benzo[B]thiophene nucleus. Tetrahedron Letters. 14(28). 2593–2594. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert M. OʼBryan Breakdown of academic impact, for papers by Salitha Reddy Breakdown of academic impact, for papers by Hugh L. Davis Breakdown of academic impact, for papers by John J. Gullo Breakdown of academic impact, for papers by Virginie Lucas Breakdown of academic impact, for papers by Jean Marc Extra Breakdown of academic impact, for papers by M. De Lena Breakdown of academic impact, for papers by Giuseppe Fraschini Breakdown of academic impact, for papers by G. Pérez-Manga Breakdown of academic impact, for papers by Gladys Rodriguez
Rankless by CCL
2026